Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies

New Biotechnology

Volumn 25, Issue 4, 2009, Pages 226-234

  Patient, Romuald ^a   Hourioux, Christophe ^a   Vaudin, Pascal ^a   Pagès, Jean Christophe ^a   Roingeard, Philippe ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEINS; FUSION PROTEINS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS-B; N TERMINALS; PARTICLE ASSEMBLIES; TRANS-MEMBRANE PROTEINS; TRANSMEMBRANE DOMAINS;

ACTIVATION ANALYSIS; CELL MEMBRANES; HYPERSONIC AERODYNAMICS; VACCINES; VIRUSES;

PROTEINS;

ENVELOPE PROTEIN; GLYCOPROTEIN E1; GLYCOPROTEIN E2; HEPATITIS B VACCINE; HEPATITIS VACCINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; VIRUS CARRIER; VIRUS ENVELOPE; VIRUS PARTICLE;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; DRUG DESIGN; HEPACIVIRUS; HEPATITIS B VIRUS; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIRION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 67349209526     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbt.2009.01.001     Document Type: Article

References (34)

1. Doan L.X., et al. Virus-like particles as HIV-1 vaccines. Rev. Med. Virol. 15 (2005) 75-88
2. Schreckenberger C., and Kaufmann A.M. Vaccination strategies for the treatment and prevention of cervical cancer. Curr. Opin. Oncol. 16 (2004) 485-491
3. McAleer W.J., et al. Human hepatitis B vaccine from recombinant yeast. Nature 307 (1984) 178-180
4. Delpeyroux F., et al. A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles. Science 233 (1986) 472-475
5. Delpeyroux F., et al. Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles. J. Virol. 64 (1990) 6090-60100
6. Lee I.H., et al. Presentation of the hydrophilic domains of hepatitis C viral E2 envelope glycoprotein on hepatitis B surface antigen particles. J. Med. Virol. 50 (1996) 145-151
7. Netter H.J., et al. Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes. J. Virol. 75 (2001) 2130-2141
8. Berkower I., et al. Assembly, structure, and antigenic properties of virus-like particles rich in HIV-1 envelope gp120. Virology 321 (2004) 75-86
9. Eckhart L., et al. Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus. J. Gen. Virol. 77 (1996) 2001-2008
10. Michel M.L., et al. Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV - hepatitis B surface antigen particles. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 7957-7961
11. Phogat S., et al. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles. Virology 373 (2008) 72-84
12. Von Brunn A., et al. Epitopes of the human malaria parasite P. falciparum carried on the surface of HBsAg particles elicit an immune response against the parasite. Vaccine 9 (1991) 477-484
13. Bruss V. Envelopment of the hepatitis B virus nucleocapsid. Virus Res. 106 (2004) 199-209
14. Eble B.E., et al. Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen. Mol. Cell Biol. 7 (1987) 3591-3601
15. Stirk H.J., et al. A topological model for hepatitis B surface antigen. Intervirology 33 (1992) 148-158
16. Delpeyroux F., et al. Insertions in the hepatitis B surface antigen: effect on assembly and secretion of 22-nm particles from mammalian cells. J. Mol. Biol. 195 (1987) 343-350
17. Lambert C., et al. Functional incorporation of green fluorescent protein into hepatitis B virus envelope particles. Virology 330 (2004) 158-167
18. Houghton M., and Abrignani S. Prospects for a vaccine against the hepatitis C virus. Nature 436 (2005) 961-966
19. Duvet S., et al. Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval. J. Biol. Chem. 273 (1998) 32088-32095
20. Hourioux C., et al. Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane. Cell Microbiol. 9 (2007) 1014-1027
21. Forns X., et al. The challenge of developing a vaccine against hepatitis C virus. J. Hepatol. 37 (2002) 684-695
22. Flint M., et al. Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein. J. Virol. 74 (2000) 702-709
23. Patient R., et al. Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking. J. Virol. 81 (2007) 3842-3851
24. Blanchard E., et al. Hepatitis C virus-like particle morphogenesis. J. Virol. 76 (2002) 4073-4079
25. Santolini E., et al. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J. Virol. 73 (1999) 3351-3358
26. Jenna S., and Sureau C. Mutations in the carboxyl-terminal domain of the small hepatitis B virus envelope protein impair the assembly of hepatitis delta virus particles. J. Virol. 73 (1999) 3351-3358
27. Deleersnyder V., et al. Formation of native hepatitis C virus glycoprotein complexes. J. Virol. 71 (1997) 697-704
28. Dull T., et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72 (1998) 8463-8471
29. Michel M.-L., et al. Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc. Natl. Acad. Sci. U. S. A. 24 (1984) 7708-7712
30. Meunier J.C., et al. Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex. J. Gen. Virol. 80 (1999) 887-896
31. Pavio N., et al. Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR. J. Virol. 76 (2002) 1265-1672
32. Bruss V., and Ganem D. Mutational analysis of hepatitis B surface antigen particle assembly and secretion. J. Virol. 65 (1991) 3813-3820
33. Prange R., et al. Deletions in the hepatitis B virus small envelope protein: effect on assembly and secretion of surface antigen particles. J. Virol. 66 (1992) 5832-5841
34. Gavilanes F., et al. Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins. J. Biol. Chem. 257 (1982) 7770-7777